{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:30:29Z","timestamp":1789705829606,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.leukres.2013.07.019","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T14:00:42Z","timestamp":1376402442000},"page":"1278-1286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib"],"prefix":"10.1016","volume":"37","author":[{"given":"Tatsuki","family":"Shibuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Shiotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Vellasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Shiratsuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukuru","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.07.019_bib0005","first-page":"6","article-title":"Chronic myeloid leukemia: molecular monitoring in clinical practice","volume":"37","author":"Branford","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.leukres.2013.07.019_bib0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2217\/epi.11.73","article-title":"Epigenomics of leukemia: from mechanisms to therapeutic applications","volume":"3","author":"Florean","year":"2011","journal-title":"Epigenomics"},{"issue":"5439","key":"10.1016\/j.leukres.2013.07.019_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.286.5439.481","article-title":"Epigenetics: regulation through repression","volume":"286","author":"Wolffe","year":"1999","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.leukres.2013.07.019_bib0020","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ejca.2009.04.005","article-title":"Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia","volume":"45","author":"San Jos\u00e9-Eneriz","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2002-09-2834","article-title":"p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia","volume":"101","author":"Kusy","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12185-012-1106-x","article-title":"Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia","volume":"96","author":"Yang","year":"2012","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1016\/j.leukres.2013.07.019_bib0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrm2950","article-title":"Active DNA demethylation: many roads lead to Rome","volume":"11","author":"Wu","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.leukres.2013.07.019_bib0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jb\/mvq113","article-title":"Emerging complexity of microRNA generation cascades","volume":"149","author":"Suzuki","year":"2011","journal-title":"J Biochem"},{"issue":"2","key":"10.1016\/j.leukres.2013.07.019_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.leukres.2013.07.019_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs \u2013 microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgl185","article-title":"MicroRNAs in biological processes and carcinogenesis","volume":"28","author":"Osada","year":"2007","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.leukres.2013.07.019_bib0065","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/leu.2008.30","article-title":"MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications","volume":"22","author":"Fabbri","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2013.07.019_bib0070","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","article-title":"MicroRNAs in cancer management","volume":"13","author":"Kong","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.leukres.2013.07.019_bib0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1349-7006.2012.02236.x","article-title":"Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells","volume":"103","author":"Kozaki","year":"2012","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.leukres.2013.07.019_bib0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.leukres.2013.07.019_bib0085","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-08-4025","article-title":"Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia","volume":"69","author":"Agirre","year":"2009","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.leukres.2013.07.019_bib0090","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.0800121105","article-title":"MiR-15a and miR-16-1 cluster functions in human leukemia","volume":"105","author":"Calin","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.leukres.2013.07.019_bib0095","doi-asserted-by":"crossref","first-page":"e35501","DOI":"10.1371\/journal.pone.0035501","article-title":"Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells","volume":"7","author":"Rokah","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.leukres.2013.07.019_bib0100","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.leukres.2009.04.039","article-title":"MicroRNAs in normal and malignant myelopoiesis","volume":"33","author":"Pelosi","year":"2009","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.leukres.2011.08.023","article-title":"miRNA-451: a putative predictor marker of imatinib therapy response in chronic myeloid leukemia","volume":"36","author":"Scholl","year":"2012","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.leukres.2013.07.019_bib0110","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.leu.2403764","article-title":"Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL\u2013 inhibition of P-glycoprotein function by 17-AAG","volume":"19","author":"Radujkovic","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2013.07.019_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s002800051001","article-title":"Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor: activity on lineage-committed and primitive chronic myelogenous leukemia progenitors","volume":"44","author":"Kasper","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.leukres.2013.07.019_bib0120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.molcel.2011.09.012","article-title":"MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation","volume":"44","author":"Suzuki","year":"2011","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/epi.10.74","article-title":"DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family","volume":"3","author":"Wong","year":"2011","journal-title":"Epigenomics"},{"issue":"4","key":"10.1016\/j.leukres.2013.07.019_bib0130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgq033","article-title":"Epigenetic inactivation of the miR-34a in hematological malignancies","volume":"31","author":"Chim","year":"2010","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.leukres.2013.07.019_bib0135","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1158\/1078-0432.CCR-11-2450","article-title":"Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers","volume":"18","author":"Heller","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"31","key":"10.1016\/j.leukres.2013.07.019_bib0140","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/onc.2011.62","article-title":"MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia","volume":"30","author":"Gao","year":"2011","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.leukres.2013.07.019_bib0145","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","article-title":"Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer","volume":"68","author":"Kozaki","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.leukres.2013.07.019_bib0150","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/carcin\/bgp250","article-title":"miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma","volume":"31","author":"Furuta","year":"2010","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.leukres.2013.07.019_bib0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2011.08782.x","article-title":"Epigenetic silencing of MIR203 in multiple myeloma","volume":"154","author":"Wong","year":"2011","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.leukres.2013.07.019_bib0160","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1158\/0008-5472.CAN-10-3907","article-title":"Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives helicobacter-associated gastric lymphomagenesis","volume":"71","author":"Craig","year":"2011","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.leukres.2013.07.019_bib0165","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","article-title":"Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth","volume":"6","author":"Agirre","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"5","key":"10.1016\/j.leukres.2013.07.019_bib0170","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V97.5.1172","article-title":"Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia","volume":"97","author":"Mizuno","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2013.07.019_bib0175","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1038\/bcj.2011.33","article-title":"Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins","volume":"1","author":"Nishioka","year":"2011","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.leukres.2013.07.019_bib0180","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2007-03-078576","article-title":"Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome","volume":"110","author":"Soriano","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2013.07.019_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18632\/oncotarget.106","article-title":"Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome","volume":"1","author":"Raffoux","year":"2010","journal-title":"Oncotarget"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:58:45Z","timestamp":1758934725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613002464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0145212613002464"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.019","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}